1. Prostate cancer screening using a combination of risk-prediction, MRI, and targeted prostate biopsies (STHLM3-MRI): a prospective, population-based, randomised, open-label, non-inferiority trial. Issue 9 (September 2021) Authors: Nordström, Tobias; Discacciati, Andrea; Bergman, Martin; Clements, Mark; Aly, Markus; Annerstedt, Magnus; Glaessgen, Axel; Carlsson, Stefan; Jäderling, Fredrik; Eklund, Martin; Grönberg, Henrik; Cavalli-Björkman, Carin; Björklund, Astrid; Hune, Britt-Marie; Clements, Mark; Hao, Shuang; Discacciat... Journal: Lancet oncology Issue: Volume 22:Issue 9(2021) Page Start: 1240 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗